Page 332 - Read Online

Page 8 of 10 Yao et al. Hepatoma Res 2018;4:30 I http://dx.doi.org/10.20517/2394-5079.2018.32

2018;48:127-33.
8. Chen LP, Zhao J, Du Y, Han YF, Su T, Zhang HW, Cao GW. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular
carcinoma. World J Virol 2012;1:174-83.
9. Seto WK, Yuen MF. Nonalcoholic fatty liver disease in Asia: emerging perspectives. J Gastroenterol 2017;52:164-74.
10. Margini C, Dufour JF. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver Int
2016;36:317-24.
11. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao GW. Factors predicting occurrence and prognosis of hepatitis-B-virus-related
hepatocellular carcinoma. World J Gastroenterol 2011;17:4258-70.
12. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009;15:5761-9.
13. Pan L, Yao M, Yao D. Clinical significance of abnormal Wnt signaling pathway expression in hepatitis and hepatocellular carcinoma.
Zhonghua Gan Zang Bing Za Zhi 2015;23:797-800. (in Chinese)
14. Rinninella E, Cerrito L, Spinelli I, Cintoni M, Mele MC, Pompili M, Gasbarrini A. Chemotherapy for hepatocellular carcinoma: current
evidence and future perspectives. J Clin Transl Hepatol 2017;5:235-48.
15. Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene 2017;36:1461-73.
16. Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, Umeshita K,
Matsuura N, Matsubara K, Doki Y, Mori M, Monden M.. Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to
interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer 2009;100:1647-58.
17. Yao DF, Huang ZW, Chen SZ, Huang JF, Lu JX, Xiao MB, Meng XY. Diagnosis of hepatocellular carcinoma by quantitative detection of
hepatoma-specific bands of serum gamma-glutamyltransferase. Am J Clin Pathol 1998;110:743-9.
18. Yao M, Yao DF, Bian YZ, Zhang CG, Qiu LW, Wu W, Sai WL, Yang JL, Zhang HJ. Oncofetal antigen glypican-3 as a promising early
diagnostic marker for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011;10:289-94.
19. Pan LH, Yao M, Zheng WJ, Gu JJ, Yang XL, Qiu LW, Cai Y, Wu W, Yao DF. Abnormality of Wnt3a expression as novel specific
biomarker for diagnosis and differentiation of hepatocellular carcinoma. Tumour Biol 2016;37:5561-8.
20. Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang L, Yao DF. Oncogenic Wnt3a expression as an estimable prognostic marker for
hepatocellular carcinoma. World J Gastroenterol 2016;22:3829-37.
21. Miller JR. The Wnts. Genome Biol 2002;3:3001.
22. Arheden K, Mandahl N, Strombeck B, Isaksson M, Mitelman F. Chromosome localization of the human oncogene INT1 to 12q13 by in
situ hybridization. Cytogenet Cell Genet 1988;3:86-7.
23. McMahon JA, McMahon AP. Nucleotide sequence, chromosomal localization and developmental expression of the mouse int-1-related
gene. Development 1989;3:643-50.
24. Katoh M, Hirai M, Sugimura T, Terada M. Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene
family. Oncogene 1996;3:873-6.
25. Roelink H, Wang J, Black DM, Solomon E, Nusse R. Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene.
Genomics 1993;3:790-2.
26. Roelink H, Nusse R. Expression of two members of the Wnt family during mouse development-restricted temporal and spatial patterns in
the developing neural tube. Genes Dev 1991;3:381-8.
27. Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL. Differential expression of human Wnt genes 2, 3, 4, and 7B in human
breast cell lines and normal and disease states of human breast tissue. Cancer Res 1994;3:2615-21.
28. Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepato- cellular carcinoma associated with poor
prognosis. World J Gastroenterol 2012;18:1328-38.
29. Saitoh T, Katoh M. Molecular cloning and characterization of human WNT5B on chromosome 12p13.3 region. Int J Oncol 2001;3:347-51.
30. Kirikoshi H, Sekihara H, Katoh M. WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are
strongly coexpressed in SW480 cells. Biochem Biophys Res Commun 2001;3:798-805.
31. Ikegawa S, Kumano Y, Okui K, Fujiwara T, Takahashi E, Nakamura Y. Isolation, characterization and chromosomal assignment of the
human WNT7A gene. Cytogenet Cell Genet 1996;3:149-52.
32. Kirikoshi H, Sekihara H, Katoh M. Molecular cloning and characterization of human WNT7B. Int J Oncol 2001;3:779-83.
33. Saitoh T, Katoh M. Molecular cloning and characterization of human WNT8A. Int J Oncol 2001;3:123-27.
34. Lako M, Lindsay S, Bullen P, Wilson DI, Robson SC, Strachan T. A novel mammalian wnt gene, WNT8B, shows brain-restricted
expression in early development, with sharply delimited expression boundaries in the developing fore-brain. Hum Mol Genet
1998;3:813-22.
35. Bui TD, Rankin J, Smith K, Huguet EL, Ruben S, Strachan T, Harris AL, Lindsay S. A novel human Wnt gene, WNT10B, maps to 12q13
and is expressed in human breast carcinomas. Oncogene 1997;3:1249-53.
36. Lako M, Strachan T, Bullen P, Wilson DI, Robson SC, Lindsay S. Isolation, characterisation and embryonic expression of WNT11, a gene
which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 1998;3:101-10.
37. Bergstein I, Eisenberg LM, Bhalerao J, Jenkins NA, Copeland NG, Osborne MP, Bowcock AM, Brown AM. Isolation of two novel WNT
genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21. Genomics 1997;3:450-8.
38. Fear MW, Kelsell DP, Spurr NK, Barnes MR. Wnt-16a, a novel Wnt-16 isoform, which shows differential expression in adult human
tissues. Biochem Biophys Res Commun 2000;3:814-20.
39. Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B. Notch and Wnt/β-catenin signaling pathway play
important roles in activating liver cancer stem cells. Oncotarget 2016;7:5754-68.